APO RESEARCH · REPORT
Alvimopan
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Product & engineering
Understand the product.
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Selected research
Industry Growth & Trends
Global Alvimopan Industry Growth and Trends Forecast to 2032
Market perspective
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Alvimopan market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Alvimopan market size, estimates, and forecasts are presented in terms of sales volume (KG) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alvimopan market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alvimopan.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Alvimopan market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Alvimopan Market by Company
Merck
Teva Pharmaceutical Industries Ltd
MSN Life Sciences Private Ltd
Alvimopan Segment by Type
Pharmaceutical Grade
Others
Alvimopan Segment by Application
Pharmaceutical
Other
Alvimopan Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alvimopan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alvimopan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alvimopan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alvimopan manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Alvimopan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Grade
- Others
Applications
- Pharmaceutical
- Other
Companies covered
- Merck
- Teva Pharmaceutical Industries Ltd
- MSN Life Sciences Private Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Alvimopan Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Alvimopan Sales Estimates and Forecasts (2021-2032)
- 1.3 Alvimopan Market by Type
- 1.3.1 Pharmaceutical Grade
- 1.3.2 Others
- 1.4 Global Alvimopan Market Size by Type
- 1.4.1 Global Alvimopan Market Size Overview by Type (2021-2032)
- 1.4.2 Global Alvimopan Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Alvimopan Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Alvimopan Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Alvimopan Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Alvimopan Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Alvimopan Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Alvimopan Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Alvimopan Industry Trends
- 2.2 Alvimopan Industry Drivers
- 2.3 Alvimopan Industry Opportunities and Challenges
- 2.4 Alvimopan Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Alvimopan Revenue (2021-2026)
- 3.2 Global Top Players by Alvimopan Sales (2021-2026)
- 3.3 Global Top Players by Alvimopan Price (2021-2026)
- 3.4 Global Alvimopan Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Alvimopan Major Company Production Sites & Headquarters
- 3.6 Global Alvimopan Company, Product Type & Application
- 3.7 Global Alvimopan Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Alvimopan Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Alvimopan Players Market Share by Revenue in 2025
- 3.8.3 2025 Alvimopan Tier 1, Tier 2, and Tier 3
4 Alvimopan Regional Status and Outlook
- 4.1 Global Alvimopan Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Alvimopan Historic Market Size by Region
- 4.2.1 Global Alvimopan Sales in Volume by Region (2021-2026)
- 4.2.2 Global Alvimopan Sales in Value by Region (2021-2026)
- 4.2.3 Global Alvimopan Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Alvimopan Forecasted Market Size by Region
- 4.3.1 Global Alvimopan Sales in Volume by Region (2027-2032)
- 4.3.2 Global Alvimopan Sales in Value by Region (2027-2032)
- 4.3.3 Global Alvimopan Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alvimopan by Application
- 5.1 Alvimopan Market by Application
- 5.1.1 Pharmaceutical
- 5.1.2 Other
- 5.2 Global Alvimopan Market Size by Application
- 5.2.1 Global Alvimopan Market Size Overview by Application (2021-2032)
- 5.2.2 Global Alvimopan Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Alvimopan Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Alvimopan Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Alvimopan Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Alvimopan Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Alvimopan Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Alvimopan Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck Alvimopan Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Merck Alvimopan Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Teva Pharmaceutical Industries Ltd
- 6.2.1 Teva Pharmaceutical Industries Ltd Company Information
- 6.2.2 Teva Pharmaceutical Industries Ltd Business Overview
- 6.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio
- 6.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
- 6.3 MSN Life Sciences Private Ltd
- 6.3.1 MSN Life Sciences Private Ltd Company Information
- 6.3.2 MSN Life Sciences Private Ltd Business Overview
- 6.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 MSN Life Sciences Private Ltd Alvimopan Product Portfolio
- 6.3.5 MSN Life Sciences Private Ltd Recent Developments
7 North America by Country
- 7.1 North America Alvimopan Sales by Country
- 7.1.1 North America Alvimopan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Alvimopan Sales by Country (2021-2026)
- 7.1.3 North America Alvimopan Sales Forecast by Country (2027-2032)
- 7.2 North America Alvimopan Market Size by Country
- 7.2.1 North America Alvimopan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Alvimopan Market Size by Country (2021-2026)
- 7.2.3 North America Alvimopan Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Alvimopan Sales by Country
- 8.1.1 Europe Alvimopan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Alvimopan Sales by Country (2021-2026)
- 8.1.3 Europe Alvimopan Sales Forecast by Country (2027-2032)
- 8.2 Europe Alvimopan Market Size by Country
- 8.2.1 Europe Alvimopan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Alvimopan Market Size by Country (2021-2026)
- 8.2.3 Europe Alvimopan Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Alvimopan Sales by Country
- 9.1.1 Asia-Pacific Alvimopan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Alvimopan Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Alvimopan Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Alvimopan Market Size by Country
- 9.2.1 Asia-Pacific Alvimopan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Alvimopan Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Alvimopan Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Alvimopan Sales by Country
- 10.1.1 South America Alvimopan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Alvimopan Sales by Country (2021-2026)
- 10.1.3 South America Alvimopan Sales Forecast by Country (2027-2032)
- 10.2 South America Alvimopan Market Size by Country
- 10.2.1 South America Alvimopan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Alvimopan Market Size by Country (2021-2026)
- 10.2.3 South America Alvimopan Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Alvimopan Sales by Country
- 11.1.1 Middle East and Africa Alvimopan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Alvimopan Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Alvimopan Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Alvimopan Market Size by Country
- 11.2.1 Middle East and Africa Alvimopan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Alvimopan Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Alvimopan Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Alvimopan Value Chain Analysis
- 12.1.1 Alvimopan Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Alvimopan Production Mode & Process
- 12.2 Alvimopan Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Alvimopan Distributors
- 12.2.3 Alvimopan Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst